Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer

Clinical trial NCT05561686 · UNKNOWN

Trial details

NCT number: NCT05561686
Sponsor: Hunan Cancer Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

HER2-positive Breast Cancer

Start date: 2022-10-01
Primary completion: 2024-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.